Jinling Pharmaceutical Company Limited reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 693.02 million compared to CNY 701.6 million a year ago. Revenue was CNY 693.02 million compared to CNY 701.6 million a year ago. Net income was CNY 39.24 million compared to CNY 35 million a year ago. Basic earnings per share from continuing operations was CNY 0.0769 compared to CNY 0.0694 a year ago. Diluted earnings per share from continuing operations was CNY 0.0769 compared to CNY 0.0694 a year ago.